Kenneth Allen Myszkowski, Chief Financial Officer at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 60,150 shares at $71.77 ($4.4M) on 2021-01-06, disclosed to the SEC on 2021-01-07.
Seasonal sale ($4.4M) by Chief Financial Officer — this insider has traded ARWR in January in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $70.75 | 1,100 | $78K | 1.8% |
| 2 | $71.77 | 4,359 | $313K | 7.2% |
| 3 | $71.77 | 4,359 | $313K | 7.2% |
| 4 | $72.63 | 25,166 | $1.8M | 41.9% |
| 5 | $72.63 | 25,166 | $1.8M | 41.9% |
| Total | $72.47 avg | 60,150 |
| $4.4M |
| 100% |
| Filing → |
| ARWR | SELL | 2024-01-08 | $885K | — | Filing → |
| ARWR | SELL | 2023-06-29 | $543K | — | Filing → |
| ARWR | SELL | 2022-12-30 | $1.2M | — | Filing → |